ALA shows promise in reducing diabetes risk in schizophrenia patients on antipsychotics
A new study found that alpha-lipoic acid may help reduce diabetes risk in people with schizophrenia treated with antipsychotic medications.
A new study found that alpha-lipoic acid may help reduce diabetes risk in people with schizophrenia treated with antipsychotic medications.